Stocksigma LogoStocksigma Logo

Hester Biosciences Posts Strong Q2 FY27 Results; Approves Loan to Africa Arm

Hester Biosciences reported strong consolidated Q2 FY27 earnings, with revenue rising 38% YoY to INR 979.12m and PAT increasing 44% YoY to INR 206.31m

Hester Biosciences Posts Strong Q2 FY27 Results; Approves Loan to Africa Arm

Hester Biosciences Ltd 路 Press Release 路 05 Nov 2026, 4:46 pm

Hester Biosciences Posts Strong Q2 FY27 Results; Approves Loan to Africa Arm Hester Biosciences reported strong consolidated Q2 FY27 earnings, with revenue rising 38% YoY to INR 979.12m and PAT increasing 44% YoY to INR 206.31m. Consolidated EBITDA grew 55% YoY to INR 365.16m, with margins expanding to 37%. Standalone revenue rose 28% YoY to INR 829.28m, while standalone PAT surged 131% YoY to INR 166.60m. Additionally, the Board approved an unsecured loan of USD 1m at 9% p.a. for a 3-year tenure to its wholly-owned subsidiary, Hester Biosciences Africa Limited, to fund working capital and corporate requirements.

Original exchange filing (PDF)

More announcements from Hester Biosciences Ltd

All Hester Biosciences Ltd announcements